Oxaliplatin: its use in epithelial ovarian carcinoma

被引：0
|
作者：
Bermudez, A [1 ]
Snaidas, L [1 ]
Paniceres, G [1 ]
Sardi, J [1 ]
机构：
[1] Univ Hosp, Gynecol Oncol Unit, Buenos Aires, DF, Argentina
来源：
7TH BIENNIAL MEETING OF THE INTERNATIONAL GYNECOLOGIC CANCER SOCIETY | 1999年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aims of this study were to evaluate the response and toxicity rates of this new platinum analogue in patients with advanced or recurrent epithelial ovarian carcinoma.
引用
收藏
页码：187 / 190
页数：4
相关论文
共 50 条
  • [1] Afatinib use in recurrent epithelial ovarian carcinoma
    Shepherd-Littlejohn, Amanda L.
    Hanft, Wyatt J.
    Kennedy, Vanessa A.
    Alvarez, Edwin A.
    GYNECOLOGIC ONCOLOGY REPORTS, 2019, 29 : 70 - 72
  • [2] Bevacizumab and its use in epithelial ovarian cancer
    Matulonis, Ursula A.
    FUTURE ONCOLOGY, 2011, 7 (03) : 365 - 379
  • [3] Clinical application of oxaliplatin in epithelial ovarian cancer
    Fu, S.
    Kavanagh, J. J.
    Hu, W.
    Bast, R. C., Jr.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (05) : 1717 - 1732
  • [4] Epithelial ovarian carcinoma
    Kristensen, GB
    Trope, C
    LANCET, 1997, 349 (9045): : 113 - 117
  • [5] Whence epithelial ovarian carcinoma?
    Boyd, Jeff
    GYNECOLOGIC ONCOLOGY, 2008, 109 (02) : 161 - 163
  • [6] Aflibercept in epithelial ovarian carcinoma
    Moroney, John W.
    Sood, Anil K.
    Coleman, Robert L.
    FUTURE ONCOLOGY, 2009, 5 (05) : 591 - 600
  • [7] Mucinous epithelial ovarian carcinoma
    Perren, T. J.
    ANNALS OF ONCOLOGY, 2016, 27 : 53 - 57
  • [8] Farletuzumab in epithelial ovarian carcinoma
    Spannuth, Whitney A.
    Sood, Anil K.
    Coleman, Robert L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 431 - 437
  • [9] Epithelial ovarian carcinoma - a perspective
    Renavikar, Pranav S.
    Chen, Jie
    Lele, Subodh M.
    JOURNAL OF HISTOTECHNOLOGY, 2023, 46 (02) : 55 - 56
  • [10] Experiences with the use of oxaliplatin in esophageal carcinoma
    Albertsson, M
    Kadar, L
    Bergenfeldt, M
    ACTA ONCOLOGICA, 2006, 45 (01) : 103 - 105
12345